|
CCDC7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.09620107330488E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.89909999526972E-08 |
| Normal-vs-Stage2 |
9.37919997223702E-09 |
| Normal-vs-Stage3 |
3.11339842795633E-11 |
| Normal-vs-Stage4 |
7.18136661248536E-12 |
| Stage1-vs-Stage2 |
1.760630E-01 |
| Stage1-vs-Stage3 |
1.976260E-02 |
| Stage1-vs-Stage4 |
1.884120E-03 |
| Stage2-vs-Stage3 |
5.135600E-01 |
| Stage2-vs-Stage4 |
1.426790E-01 |
| Stage3-vs-Stage4 |
4.166000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82742709853301E-13 |
| Normal-vs-AfricanAmerican |
1.7206799999947E-05 |
| Normal-vs-Asian |
2.41709999999618E-05 |
| Caucasian-vs-AfricanAmerican |
9.112400E-01 |
| Caucasian-vs-Asian |
1.829970E-01 |
| AfricanAmerican-vs-Asian |
4.859600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.60556029477266E-12 |
| Normal-vs-Female |
1.11150000314808E-09 |
| Male-vs-Female |
8.967500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.57739998840611E-09 |
| Normal-vs-Age(41-60Yrs) |
2.96269675459371E-11 |
| Normal-vs-Age(61-80Yrs) |
3.12569999993961E-07 |
| Normal-vs-Age(81-100Yrs) |
4.589200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.852200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.953600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.871800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.394400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.376800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.897200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.2464999999916E-05 |
| Classical-VS-Follicular |
2.486100E-02 |
| Classical-VS-Other |
6.662800E-01 |
| Classical-VS-Normal |
2.33779662295319E-11 |
| Tall-VS-Follicular |
3.44479999969671E-07 |
| Tall-VS-Other |
7.877900E-03 |
| Tall-VS-Normal |
1.63136171238421E-12 |
| Follicular-VS-Other |
7.089800E-01 |
| Follicular-VS-Normal |
3.023100E-04 |
| Other-VS-Normal |
1.882100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.87609999652483E-09 |
| Normal-vs-N1 |
4.59819999965028E-07 |
| N0-vs-N1 |
6.528800E-01 |
|
|
